BIOGEN INC. SG&A Expense 2007-2026 | BIIB
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is BIOGEN INC.'s current sg&a expense?
BIOGEN INC. (BIIB) annual sg&a expense for 2025 was $2.43B, a 1.24% increase from 2024. BIOGEN INC. sg&a expense for the quarter ending March 31, 2026 was $607.3M.
What was BIOGEN INC.'s sg&a expense in 2024?
BIOGEN INC. annual sg&a expense for 2024 was $2.40B, a 5.73% decline from 2023.
What was BIOGEN INC.'s sg&a expense in 2023?
BIOGEN INC. annual sg&a expense for 2023 was $2.55B, a 6.08% increase from 2022.
What is BIOGEN INC.'s 5-year sg&a expense CAGR?
BIOGEN INC. sg&a expense grew at a compound annual growth rate (CAGR) of 0.57% from FY2020 to FY2025, going from $2.50B to $2.43B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.6%
FY2020
$2.50B
→
FY2025
$2.43B
07080910111213141516171819202122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.43B | +1.2% | 10-K |
| FY2024 | $2.40B | -5.7% | 10-K |
| FY2023 | $2.55B | +6.1% | 10-K |
| FY2022 | $2.40B | -10.1% | 10-K |
| FY2021 | $2.67B | +6.8% | 10-K |
| FY2020 | $2.50B | +5.5% | 10-K |
| FY2019 | $2.37B | +12.7% | 10-K |
| FY2018 | $2.11B | +8.9% | 10-K |
| FY2017 | $1.93B | -0.7% | 10-K |
| FY2016 | $1.95B | -7.9% | 10-K |
| FY2015 | $2.11B | -5.3% | 10-K |
| FY2014 | $2.23B | +30.4% | 10-K |
| FY2013 | $1.71B | +34.0% | 10-K |
| FY2012 | $1.28B | +21.0% | 10-K |
| FY2011 | $1.06B | +2.4% | 10-K |
| FY2010 | $1.03B | +13.2% | 10-K |
| FY2009 | $911.0M | -1.5% | 10-K |
| FY2008 | $925.3M | +19.2% | 10-K |
| FY2007 | $776.1M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →